1800 202 8726
Understanding your results

Raised Tumour Markers: — Is a Biopsy the Next Step?

A high tumour marker result is frightening. It is also not a diagnosis. Many things can raise these numbers, and a biopsy is not automatically the next step — the clinical picture decides.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Not a diagnosis on its own — No tumour marker is specific enough to confirm cancer without imaging and clinical assessment.
  • False rises are common — Infection, benign growths, liver disease, and even smoking can push markers above the normal range.
  • The trend matters more than a single number — A mildly elevated marker that stays stable is very different from one that keeps rising.
  • Your doctor decides — not the number — The biopsy decision depends on the full picture: imaging, symptoms, history, and the degree of elevation.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A raised tumour marker is not a cancer diagnosis. These numbers can rise for many reasons that have nothing to do with cancer. Your oncologist will look at the marker alongside imaging, symptoms, and your full clinical picture before deciding whether a biopsy is the right next step.

Do raised tumour markers mean you have cancer?

No. Tumour markers are proteins or substances the body produces naturally — and many conditions can push them above the normal range.

None of the commonly used markers is specific enough to diagnose cancer on its own. A high number is a prompt to investigate further, not a verdict.

If you have received a high result, what you have is the beginning of a process. What that process leads to depends on everything else your doctor finds, not on the number alone.

What else can raise a tumour marker other than cancer?

  • Infection or active inflammation anywhere in the body
  • Benign growths — fibroids, ovarian cysts, or an enlarged prostate (BPH)
  • Liver disease, including fatty liver, hepatitis, or cirrhosis
  • Kidney disease, which affects how some markers are cleared
  • Pregnancy or recent childbirth
  • Smoking — raises CEA even without any lung or bowel disease
  • Recent surgery or physical trauma near the organ being tested
  • Some prescribed medicines — ask your treating team which ones

What does your doctor decide after a high marker result?

Your oncologist will not make a biopsy decision on the marker number alone. They will consider how high the result is, how quickly it has risen, what imaging shows, and whether you have symptoms that fit.

A mildly elevated marker with no suspicious findings on imaging usually leads to a repeat test within a few weeks. The direction of travel — rising, stable, or falling — tells more than any single reading.

If imaging has found a suspicious mass, or if your symptoms suggest something needs answering urgently, a biopsy becomes the more direct path to an answer.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

When is a biopsy the likely next step?

FactorBiopsy more likely to be recommendedRepeat testing or imaging first
Marker levelMarkedly elevated or rising on repeat testingMildly elevated, stable or falling
Imaging findingsA visible mass or suspicious lesion foundNo mass found on ultrasound or CT
SymptomsPresent and fitting the organ in questionAbsent, or clearly unrelated
Personal historyPrior cancer or known high-risk factorsNo prior cancer, low-risk profile
Overall pictureEnough clinical concern to warrant tissueEnough uncertainty to justify watching first

What do the different tumour markers mean?

PSA — prostate-specific antigen

PSA rises with age, with benign prostate enlargement, urinary infections, and after prostate examination. A single elevated result is not a diagnosis. Your urologist will look at the trend, the free-to-total PSA ratio, and usually an MRI before recommending a biopsy.

CA125 — associated with ovaries and the lining of the abdomen

CA125 rises with endometriosis, ovarian cysts, fibroids, pelvic infection, and liver disease. It is used alongside ultrasound imaging, not as a standalone test. A raised result in someone still menstruating has more benign explanations than in someone who has been through the menopause.

CEA — carcinoembryonic antigen

CEA rises in smokers and in people with bowel inflammation, liver disease, or lung disease. A mildly elevated result in a smoker with no other findings is usually repeated rather than biopsied. The direction — whether it is rising, stable, or falling — drives the next decision.

AFP — alpha-fetoprotein

AFP rises with liver disease, including cirrhosis and hepatitis. In non-pregnant adults, a raised AFP prompts liver imaging rather than immediate biopsy. Whether tissue is then needed follows what the imaging shows, not the number by itself.

CA19-9 — associated with the pancreas and bile ducts

CA19-9 can rise with jaundice, gallstones, bile duct inflammation, and pancreatitis — none of which are cancer. It is used mainly to monitor people already diagnosed with pancreatic or biliary cancer, not as a screening test. A raised result in someone without a known diagnosis means imaging first.

Did you know?

Most commonly used tumour markers can be elevated in people who have no cancer at all. International guidance from ASCO and ESMO advises against using them as standalone screening tests in people with no symptoms, for exactly this reason.

A result outside the normal range is a prompt to look further — not a finding that stands alone.

Source: ASCO Clinical Practice Guidelines on Tumour Markers; ESMO guidelines on biomarker use in oncology

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

HUB — Does a Biopsy Spread Cancer? Myths and Evidence

HUB — What Is a Biopsy? Everything You Need to Know

All Understanding Your Biopsy and Whether You Need One →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does a high PSA mean I have prostate cancer?

Not necessarily, and in many cases no. PSA rises with benign prostate enlargement, urinary infection, recent prostate examination, and simply with age. A single raised reading is a reason to investigate further, not a diagnosis. Your urologist will look at the trend over several readings, the free-to-total PSA ratio, and usually an MRI before recommending a biopsy. Many men who undergo biopsy after a raised PSA are found to have no cancer.

Can I skip the biopsy if the marker is only slightly raised?

That decision belongs to your treating doctor, not to the number alone. A mildly elevated marker with no concerning symptoms and no mass on imaging often leads to a repeat test rather than an immediate biopsy. What your doctor is watching for is whether the number is rising, stable, or falling, and what the full clinical picture shows alongside it. Never decline a biopsy your oncologist has recommended without discussing the reasons directly with them.

My marker went up between two tests — does that mean it is getting worse?

A rise between two tests is worth reporting to your team, but it does not automatically mean the disease is progressing. Results can vary slightly between laboratory runs, and a single rise may reflect a benign change like a new infection rather than tumour growth. Your team will look at the size of the rise, the time between tests, and what else is happening clinically before drawing a conclusion.

Can a biopsy miss cancer that a raised marker has suggested is there?

Yes, and this is one reason your doctor chooses the biopsy site carefully. A biopsy takes a small sample from one location; if the area is sampled accurately the sensitivity is high, but if the needle misses the area or the tumour is very small, a negative result does not rule cancer out entirely. Your team will explain which site is being sampled and why. If the result is negative but concern remains, further testing may follow.

How long should I wait before repeating a high marker test?

Your doctor will decide the interval based on the clinical context — there is no single correct answer. For a mildly elevated result with no other concerns, a few weeks is common; for a significantly elevated result with concerning symptoms or imaging, the investigation moves faster. Do not repeat the test yourself at a private laboratory without telling your treating team — they need to interpret all results together.

If markers cannot diagnose cancer, what is the point of testing them?

Markers serve two purposes they are genuinely good at: monitoring a known cancer to see how it is responding to treatment, and detecting a recurrence in someone who has already been treated. As a first diagnostic step in someone with no prior cancer, they are much less reliable and always need supporting evidence before any action is taken. Your oncologist will explain which role the marker is playing in your case.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation